These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33895327)

  • 1. Evidence in primates supporting the use of chemogenetics for the treatment of human refractory neuropsychiatric disorders.
    Roseboom PH; Mueller SAL; Oler JA; Fox AS; Riedel MK; Elam VR; Olsen ME; Gomez JL; Boehm MA; DiFilippo AH; Christian BT; Michaelides M; Kalin NH
    Mol Ther; 2021 Dec; 29(12):3484-3497. PubMed ID: 33895327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DREADD-mediated amygdala activation is sufficient to induce anxiety-like responses in young nonhuman primates.
    Mueller SAL; Oler JA; Roseboom PH; Aggarwal N; Kenwood MM; Riedel MK; Elam VR; Olsen ME; DiFilippo AH; Christian BT; Hu X; Galvan A; Boehm MA; Michaelides M; Kalin NH
    bioRxiv; 2023 Jun; ():. PubMed ID: 37333300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DREADD-mediated amygdala activation is sufficient to induce anxiety-like responses in young nonhuman primates.
    Mueller SAL; Oler JA; Roseboom PH; Aggarwal N; Kenwood MM; Riedel MK; Elam VR; Olsen ME; DiFilippo AH; Christian BT; Hu X; Galvan A; Boehm MA; Michaelides M; Kalin NH
    Curr Res Neurobiol; 2023; 5():100111. PubMed ID: 38020807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemogenetic Inhibition of the Amygdala Modulates Emotional Behavior Expression in Infant Rhesus Monkeys.
    Raper J; Murphy L; Richardson R; Romm Z; Kovacs-Balint Z; Payne C; Galvan A
    eNeuro; 2019; 6(5):. PubMed ID: 31541000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral Effect of Chemogenetic Inhibition Is Directly Related to Receptor Transduction Levels in Rhesus Monkeys.
    Upright NA; Brookshire SW; Schnebelen W; Damatac CG; Hof PR; Browning PGF; Croxson PL; Rudebeck PH; Baxter MG
    J Neurosci; 2018 Sep; 38(37):7969-7975. PubMed ID: 30082415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Behavioral Manipulation via Orally Delivered Chemogenetic Actuator in Macaques.
    Oyama K; Hori Y; Nagai Y; Miyakawa N; Mimura K; Hirabayashi T; Inoue KI; Takada M; Higuchi M; Minamimoto T
    J Neurosci; 2022 Mar; 42(12):2552-2561. PubMed ID: 35110390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo electrophysiological validation of DREADD-based modulation of pallidal neurons in the non-human primate.
    Deffains M; Nguyen TH; Orignac H; Biendon N; Dovero S; Bezard E; Boraud T
    Eur J Neurosci; 2021 Apr; 53(7):2192-2204. PubMed ID: 32306446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys.
    Nagai Y; Miyakawa N; Takuwa H; Hori Y; Oyama K; Ji B; Takahashi M; Huang XP; Slocum ST; DiBerto JF; Xiong Y; Urushihata T; Hirabayashi T; Fujimoto A; Mimura K; English JG; Liu J; Inoue KI; Kumata K; Seki C; Ono M; Shimojo M; Zhang MR; Tomita Y; Nakahara J; Suhara T; Takada M; Higuchi M; Jin J; Roth BL; Minamimoto T
    Nat Neurosci; 2020 Sep; 23(9):1157-1167. PubMed ID: 32632286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A novel ligand for chemogenetic receptors, Deschloroclozapine, enables rapid and selective modulation of neuronal activity and behavior in living animals].
    Nagai Y
    Nihon Yakurigaku Zasshi; 2022; 157(4):233-237. PubMed ID: 35781451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural localization of DREADDs in monkeys.
    Galvan A; Raper J; Hu X; Paré JF; Bonaventura J; Richie CT; Michaelides M; Mueller SAL; Roseboom PH; Oler JA; Kalin NH; Hall RA; Smith Y
    Eur J Neurosci; 2019 Sep; 50(5):2801-2813. PubMed ID: 31063250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of DREADD receptor expression and function in rhesus macaques trained to discriminate ethanol.
    Allen DC; Jimenez VA; Carlson TL; Walter NA; Grant KA; Cuzon Carlson VC
    Neuropsychopharmacology; 2022 Mar; 47(4):857-865. PubMed ID: 34654906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chemogenetic actuator drugs on prefrontal cortex-dependent working memory in nonhuman primates.
    Upright NA; Baxter MG
    Neuropsychopharmacology; 2020 Oct; 45(11):1793-1798. PubMed ID: 32193513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic hM4Di-DREADD-Mediated Chemogenetic Inhibition of Forebrain Excitatory Neurons in Postnatal or Juvenile Life Does Not Alter Adult Mood-Related Behavior.
    Tiwari P; Kapri D; Pradhan A; Balakrishnan A; Chaudhari PR; Vaidya VA
    eNeuro; 2022; 9(1):. PubMed ID: 35115382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemogenetic Seizure Control with Clozapine and the Novel Ligand JHU37160 Outperforms the Effects of Levetiracetam in the Intrahippocampal Kainic Acid Mouse Model.
    Desloovere J; Boon P; Larsen LE; Goossens MG; Delbeke J; Carrette E; Wadman W; Vonck K; Raedt R
    Neurotherapeutics; 2022 Jan; 19(1):342-351. PubMed ID: 34862591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does chronic systemic injection of the DREADD agonists clozapine-N-oxide or Compound 21 change behavior relevant to locomotion, exploration, anxiety, and depression in male non-DREADD-expressing mice?
    Tran FH; Spears SL; Ahn KJ; Eisch AJ; Yun S
    Neurosci Lett; 2020 Nov; 739():135432. PubMed ID: 33080350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting-State fMRI-Based Screening of Deschloroclozapine in Rhesus Macaques Predicts Dosage-Dependent Behavioral Effects.
    Fujimoto A; Elorette C; Fredericks JM; Fujimoto SH; Fleysher L; Rudebeck PH; Russ BE
    J Neurosci; 2022 Jul; 42(29):5705-5716. PubMed ID: 35701162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemogenetics revealed: DREADD occupancy and activation via converted clozapine.
    Gomez JL; Bonaventura J; Lesniak W; Mathews WB; Sysa-Shah P; Rodriguez LA; Ellis RJ; Richie CT; Harvey BK; Dannals RF; Pomper MG; Bonci A; Michaelides M
    Science; 2017 Aug; 357(6350):503-507. PubMed ID: 28774929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and Distribution of Clozapine-N-oxide: Implications for Nonhuman Primate Chemogenetics.
    Raper J; Morrison RD; Daniels JS; Howell L; Bachevalier J; Wichmann T; Galvan A
    ACS Chem Neurosci; 2017 Jul; 8(7):1570-1576. PubMed ID: 28324647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemogenetics-mediated acute inhibition of excitatory neuronal activity improves stroke outcome.
    Wang YC; Galeffi F; Wang W; Li X; Lu L; Sheng H; Hoffmann U; Turner DA; Yang W
    Exp Neurol; 2020 Apr; 326():113206. PubMed ID: 31962128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and slice electrophysiological assessment of DREADD ligand, deschloroclozapine (DCZ) in rats.
    Nentwig TB; Obray JD; Vaughan DT; Chandler LJ
    Sci Rep; 2022 Apr; 12(1):6595. PubMed ID: 35449195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.